Salvador
Martín Algarra
Consultor Médico
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (11)
2024
-
Access to melanoma drugs in Spain: a cross-sectional survey
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583
-
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Clinical and Translational Oncology
2023
-
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775
2021
-
Evaluation of patient quality care in Spain in prevention of nausea and vomiting induced by chemotherapy
Journal of Healthcare Quality Research, Vol. 36, Núm. 3, pp. 142-149
2020
-
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Science Translational Medicine, Vol. 12, Núm. 565
2019
-
A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1754-1762
-
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma
Oncologist, Vol. 24, Núm. 10, pp. 1375-1383
2018
-
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
Therapeutic Advances in Medical Oncology, Vol. 10
2016
-
GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases
Annals of Oncology, Vol. 27, pp. vi383
2015
-
Immune checkpoint inhibitors: Therapeutic advances in melanoma
Annals of Translational Medicine, Vol. 3, Núm. 18
2002
-
Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160